Policies, Protocols & Procedures
This protocol is intended to ensure two-way communication between PHOs and pharmaceutical representatives, while simultaneously allowing programmatic staff to effectively maintain the complexity of being a universal vaccine state, providing choice and ensuring no single vaccine and/or manufacturer is favored over one or the other.